View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-0852
ICR Reference No:
201004-0920-002
Status:
Historical Active
Previous ICR Reference No:
Agency/Subagency:
HHS/CDC
Agency Tracking No:
Title:
Prevalence Survey of Healthcare Associated Infections (HAIs) and Antimicrobial Use in U.S. Acute Care Hospitals
Type of Information Collection:
New collection (Request for a new OMB Control Number)
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved with change
Conclusion Date:
05/18/2010
Retrieve Notice of Action (NOA)
Date Received in OIRA:
04/05/2010
Terms of Clearance:
OMB approves Phase 2 of this research (the limited roll-out survey in up to 30 healthcare facilities.) CDC must submit a change package for Phase 3. The package for Phase 3 must define the scope (i.e., whether facilities outside of usual EIP catchment areas will be included) as well as the results of discussions with NCHS about using the 10 EIPs areas to characterize a national estimate.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
05/31/2013
36 Months From Approved
Responses
61,480
0
0
Time Burden (Hours)
8,039
0
0
Cost Burden (Dollars)
0
0
0
Abstract:
The Centers for Disease Control and Prevention (CDC) proposes to conduct two surveys to evaluate the prevalence of healthcare-associated infections (HAIs) and antimicrobial use in acute care hospitals in multiple states. This is a three-phase project. The first phase, a small, single-city pilot survey with less than 9 respondents, is complete. Phases 2 and 3 will be conducted in collaboration with state public health authorities and with CDC's Emerging Infections Program (EIP). Phase 2 will be a limited roll-out survey involving up to 30 healthcare facilities in the 10 states with EIP sites. Phase 3, built upon experience gained in the limited roll-out, will involve up to 500 facilities in the 10 states with EIP sites using the same survey. CDC does not anticipate making changes to the data collection instrument in Phase 3.
Authorizing Statute(s):
PL:
Pub.L. 111 - 5 1
Name of Law: American Recovery and Reinvestment Act of 2009
US Code:
42 USC 241
Name of Law: Public Health Service Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
75 FR 4396
01/27/2010
30-day Notice:
Federal Register Citation:
Citation Date:
75 FR 10803
03/09/2010
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
4
IC Title
Form No.
Form Name
EIP Personnel Prevalence Survey #1, Phase 2
1
2010 HAI & Antimicrobial Use Point Prevalence Survey: Primary Team Data Collection Form
EIP Personnel Prevalence Survey #2, Phase #3
1
2010 HAI & Antimicrobial Use Point Prevalence Survey: Primary Team Data Collection Form
Infection Control Practioners Prevalence Survey #1, Phase 2
1
2010 HAI & Antimicrobial Use Point Prevalence Survey: Primary Team Data Collection Form
Infection Control Practioners Prevalence Survey #2, Phase 3
1
2010 HAI & Antimicrobial Use Point Prevalence Survey: Primary Team Data Collection Form
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
61,480
0
0
61,480
0
0
Annual Time Burden (Hours)
8,039
0
0
8,039
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
This is a new ICR submission funded under the American Recovery and Reinvestment Act of 2009.
Annual Cost to Federal Government:
$111,384
Does this IC contain surveys, censuses, or employ statistical methods?
Yes
Part B of Supporting Statement
Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002?
Yes
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
Uncollected
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
Uncollected
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
Yes
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Petunia Gissendaner 4046390164
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
04/05/2010
An official website of the United States government
The .gov means it's official.
The site is secure.
